IU receives $10M donation from grad’s family to fund brain cancer research center
IU receives $10M donation from grad’s family to fund brain cancer research center Indianapolis Business Journal
1140 материалов по теме, собраны автоматически из проверенных источников
IU receives $10M donation from grad’s family to fund brain cancer research center Indianapolis Business Journal
People with genetic cancer risk to help shape future of prevention in bold new study PA Media
World Cancer Research Day: research to transform the future of patients Hospital Clínic Barcelona
FDA Approves Lyrfigtu for FGFR2-Rearranged Cholangiocarcinoma The Clinical Trial Vanguard
Исследование показало, что риск инсульта достигает пика в первые 3 месяца после постановки диагноза рака. Vietnam.vn
Всемирный день исследования рака отмечают во всём мире 24.kz
PDS0101 Plus Pembrolizumab Shows 39.3-Month Survival in HPV16 Head and Neck Cancer The Clinical Trial Vanguard
FDA Advisory Panel Votes 7-2 to Support Galleri Multi-Cancer Blood Test The Clinical Trial Vanguard
A nationwide study presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2 has found that people with type 2 diabetes (T2D) have a higher risk of developing cancer. Cancer incidence has risen more among people with T2D than among those without…
Make a Donation Today to Help Support Amazing Cancer Researchers - Conquer Cancer, the ASCO Foundation Oncodaily
Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or continue growing. Yet some cancer cells manage to survive treatment. A new study from Texas A&M University sheds light on one reason why: Some cancer cells have a survival toolkit.
Researchers at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness—and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.
In a study focused on aggressive breast and pancreatic cancers, scientists have discovered how tumors surrounded by a protective "scaffold" of dense, scar-like tissue manage to thrive—despite the scaffold severely restricting the blood supply and nutrient delivery essential for growth.
Alireza Mansouri: Strong Momentum Generated as Part of Swedish-USA Cancer Research Collaboration Oncodaily
ImmunityBio Advances Patient-Centric Clinical Trial Design in Bladder Cancer Oncodaily